-
A Decade of Change in Turkish Healthcare Utilization: Hospital Admission Trends 2015-2024
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Access and Pricing Timelines for Innovative Medicines in the US, Europe, and Japan Pre- and Post-Pricing Reform 2021-2025
Sep 9, 2025, 16:22 PM -
Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025
Sep 9, 2025, 16:22 PM -
Gender Inequalities in Aortic and Mitral Valve Interventions in Sweden
Sep 9, 2025, 16:22 PM -
Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
Prevalence and Overlap of Overweight/Obesity Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease in England: A Clinical Practice Research Datalink Study
Sep 9, 2025, 16:22 PM -
Factors Associated With Response to Patient-Reported Outcome Measures: A Systematic Review of Systematic Reviews and Meta-analyses
Sep 9, 2025, 16:22 PM -
Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection
Sep 9, 2025, 16:22 PM -
HTA for Obesity and T2DM Indications: A Review and Recommendations for Future Appraisals
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Levofloxacin for Tuberculosis Prevention in MDR/RR-TB Contacts in High-Burden Settings
Sep 9, 2025, 16:22 PM -
Pricing Implications of Subcutaneous Reformulations Following Intravenous Launches: A Multicountry Analysis
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
A Strategic National Framework for Managed Entry Agreements to Access Innovative and Breakthrough Medications in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies
Sep 9, 2025, 16:22 PM -
Analysis of HTA Decisions in Five European Countries for High Medical Need Products Approved by EMA
Sep 9, 2025, 16:22 PM -
Impact of Different CV Risk Estimation Methods on Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Comparing ROBINS-I V2 and Downs Black for nRCTs in the Context of HTA
Sep 9, 2025, 16:22 PM -
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries
Sep 9, 2025, 16:22 PM -
The Effect of Nutritional Supplements on Semen Quality and Pregnancy Rates in Patients With Male Factor Infertility: A Systematic Literature Review and Network Meta-Analysis
Sep 9, 2025, 16:22 PM
